| Titels | Prof. dr. |
| Initials | R.H. |
| Main position | Directeur Wetenschapsbeleid, Voorzitter Raad van Bestuur NKI-AvL/hoogleraar UU |
| Disciplines | Genetics |
| Oncology | |
| Histology, cell biology | |
| Chair | Experimentele Oncologie |
| Domain | Medical, Biomedical and Health Sciences |
| Membership | Member |
| Since | 2013 |
| Chair of Jury of the Dr A.H. Heineken Prize for Medicine | |
| Member of Council for Medical Sciences | |
| Member of Medical, Biomedical and Health Sciences | |
| Employed by |
Antoni van Leeuwenhoek
Nederlands Kanker Instituut, Afdeling Celbiologie I Plesmanlaan 121 1066 CX Amsterdam tel. 020 512 1990 |
| Personal website | |
| Research/publications |
René Medema has made a major contribution to our understanding of how cell division is regulated. He studies the mechanisms that ensure genetic stability in healthy cells, specifically the functioning of cell cycle checkpoints, which monitor the fidelity of chromosome segregation during cell division. Errors in chromosome segregation play a key role in the development of cancer. Medema and his group are investigating potential cancer treatments.